Simultaneous biocatalyst production and Baeyer-Villiger oxidation for bioconversion of cyclohexanone by recombinant Escherichia coli expressing cyclohexanone monooxygenase

16Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cyclohexanone monooxygenase (CHMO) catalyzing Baeyer-Villiger oxidation converts cyclic ketones into optically pure lactones, which have been used as building blocks in organic synthesis. A recombinant Escherichia coli BL21(DE3)/pMM4 expressing CHMO originated from Acinetobacter sp. NCIB 9871 was used to produce ε-caprolactone through a simultaneous biocatalyst production and Baeyer-Villiger oxidation (SPO) process. Afed-batch process was designed to obtain high cell density for improving production of ε-caprolactone. The red-batch SPO process gave the best results, 10.2 g/L of ε-caprolactone and 0.34 g/(L · h) of productivity corresponding to a 10.5- and 3.4-fold enhancement compared with those of the batch SPO, respectively. Copyright © 2005 by Humana Press Inc. All rights of any nature whatsoever reserved.

Cite

CITATION STYLE

APA

Lee, W. H., Park, Y. C., Lee, D. H., Park, K., & Seo, J. H. (2005). Simultaneous biocatalyst production and Baeyer-Villiger oxidation for bioconversion of cyclohexanone by recombinant Escherichia coli expressing cyclohexanone monooxygenase. In Applied Biochemistry and Biotechnology - Part A Enzyme Engineering and Biotechnology (Vol. 123, pp. 827–836). Humana Press. https://doi.org/10.1007/978-1-59259-991-2_70

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free